NAFDAC has issued a warning about counterfeit Combiart Dispersible Tablets (20/120mg) circulating in Nigeria, urging the public to be cautious. These fake drugs are ineffective against malaria and pose serious health risks.
The counterfeit tablets, falsely labeled as a product of Strides Arcolab Limited in India, were discovered during NAFDAC’s surveillance operations in the Federal Capital Territory (FCT) and Rivers State. Lab tests revealed that the tablets contain no active ingredients, making them useless in treating malaria. Additionally, the packaging displayed two different manufacturing and expiry dates, as well as an invalid NAFDAC registration number, while the product’s license had expired.
Combiart is commonly used to treat uncomplicated malaria, but this counterfeit version not only fails to treat the disease but also poses dangers such as treatment failure, worsening health conditions, and even death. NAFDAC emphasized that counterfeit medicines can have severe consequences, particularly for those suffering from malaria.
Related posts:
- FG Bans Monotherapy Drugs for Malaria Treatment, Advocates for ACTs
- NAFDAC Employees Embark on Indefinite Strike Amid Promotion and Welfare Disputes
To combat this, NAFDAC has ordered increased surveillance to remove counterfeit drugs from circulation. The agency has also urged importers, distributors, and retailers to verify the authenticity of their medical supplies and ensure they come from authorized sources.
NAFDAC is advising healthcare professionals, caregivers, and the general public to remain vigilant and report any suspicious products. Reports can be made through the agency’s hotline at 0800-162-3322 or via email at [email protected]. The agency also encourages the reporting of adverse drug reactions through its Med-Safety app or the e-reporting platform on its website.
By collaborating with the World Health Organization’s (WHO) Global Surveillance and Monitoring System (GSMS), NAFDAC aims to strengthen international efforts to combat counterfeit drugs and protect public health.
